Express News | BMO Capital Maintains Outperform on Intellia Therapeutics, Lowers Price Target to $50

Benzinga9minutes ago

Intellia Therapeutics Analyst Ratings

Benzinga10minutes ago · Ratings

Express News | Intellia Therapeutics Inc : Wedbush Cuts Target Price to $10 From $14

Reuters26minutes ago

Evercore Maintains Intellia Therapeutics(NTLA.US) With Buy Rating, Cuts Target Price to $48

Moomoo News59minutes ago · Ratings

Intellia Therapeutics (NTLA) Receives a Buy From Evercore ISI

TipRanks08:25 ET · Ratings

Intellia Therapeutics Restructures to Focus on Late-Stage Programs

TipRanks07:59 ET